Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway.
Michael J StrongSabrina RoccoRussell S TaichmanGregory A ClinesNicholas J SzerlipPublished in: Journal of neuro-oncology (2021)
DCM enhances the metastatic potential of PCa with increased proliferation, migration and invasion. This phenomenon is partly mediated through the CXCR2 pathway.